Blueprint Medicines Corp (BPMC) Covered Calls

Blueprint Medicines Corp covered calls Blueprint Medicines Corpis a biopharmaceutical company. It is focused on improving the lives of patients with genomically defined diseases driven by abnormal kinase activation.

You can sell covered calls on Blueprint Medicines Corp to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BPMC (prices last updated Thu 4:16 PM ET):

Blueprint Medicines Corp (BPMC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
98.24 +1.91 98.66 100.00 264K - 4.7B
Covered Calls For Blueprint Medicines Corp (BPMC)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jul 19 100 0.50 99.50 0.5% 91.2%
Aug 16 100 5.60 94.40 5.9% 71.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Blueprint Medicines Corp. is a biopharmaceutical company, which engages in developing of kinase inhibitors for genomically defined subsets of cancer patients. It has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling the development of potent highly selective compounds against clear genomic driver targets. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.